NCT00762229View on ClinicalTrials.gov

Evaluation of LDL Cholesterol in Patients Switched From 10 to 5 Milligrams of Zetia (Ezetimibe)

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Hypercholesterolemia
Interventions
DRUG

Ezetimibe 10 mg

Ezetimibe 10 mg daily for 4 weeks

DRUG

Ezetimibe 5 mg

"Ezetimibe 5 mg daily for 4 weeks, formulated as a 10 mg tablet split in half"

Trial Locations (1)

10468

Bronx VA Medical Center, The Bronx

Sponsors
All Listed Sponsors
lead

Bronx VA Medical Center

FED

NCT00762229 - Evaluation of LDL Cholesterol in Patients Switched From 10 to 5 Milligrams of Zetia (Ezetimibe) | Biotech Hunter | Biotech Hunter